NOCION THERAPEUTICS
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment of serious conditions including cough, itch, pain and inflammation.
NOCION THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.nociontx.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
49 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Lotus Tissue Repair
Lotus Tissue Repair develops an accelerating chronic wound healing technology for the treatment dermatologic conditions such as foot ulcers.
Seal Rock Therapeutics
Seal Rock Therapeutics is a developer of small molecule inhibitors used to treat inflammatory and fibrotic conditions.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Zalicus
Zalicus discovers and develops novel-target pain therapies, including calcium channel modulator for chronic and acute inflammatory pain.
Current Employees Featured
Founder
Investors List
Canaan Partners
Canaan Partners investment in Series A - Nocion Therapeutics
Mission BioCapital
Mission BioCapital investment in Series A - Nocion Therapeutics
Partners Innovation Fund
Partners Innovation Fund investment in Series A - Nocion Therapeutics
F-Prime Capital
F-Prime Capital investment in Series A - Nocion Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-09-01 | Nocion grabs new CMO as it kicks off COVID-19 cough study |
Official Site Inspections
http://www.nociontx.com
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Nocion Therapeutics"
Home - Nocion Therapeutics
Nov 18, 2024 · We are developing “nocions”—a new kind of therapy that selectively affects actively firing nociceptors—to provide targeted, robust and sustained relief for the treatment of …See details»
Nocion Therapeutics Announces First Patient Dosed in ASPIRE …
Nov 18, 2024 · Nocion Therapeutics is a biopharmaceutical company developing novel small molecule charged sodium channel blockers called “nocions” that selectively affect actively …See details»
News - Nocion Therapeutics
Mar 4, 2024 · Nocion is developing first and potentially best in class, small molecule, permanently charged sodium channel blockers (CSCBs), called nocions, that selectively silence activated …See details»
Nocion Therapeutics, Inc. | LinkedIn
Nocion Therapeutics is a biopharmaceutical company developing novel treatments for silencing neurons. The company’s platform of unique molecular entities selectively affects inflamed...See details»
Nocion Therapeutics - Crunchbase Company Profile
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.See details»
Nocion Therapeutics Company Profile 2024: Valuation, …
Developer of a small molecule charged sodium channel designed to treat the conditions arising from neurogenic inflammation.See details»
Nocion Therapeutics Announces $62 Million Series B Financing
Mar 4, 2024 · Nocion Therapeutics is a biopharmaceutical company developing novel small molecule CSCBs, “nocions,” that selectively affect actively firing nociceptors for the treatment …See details»
Lumira Ventures Announces Investment in Nocion Therapeutics to ...
Apr 2, 2024 · TORONTO, ON / ACCESSWIRE / April 2, 2024 / Lumira Ventures is delighted to announce its latest investment in Nocion Therapeutics, a clinical-stage biopharmaceutical …See details»
Nocion Therapeutics Advances to Clinical Stage and Expands …
Sep 1, 2020 · Nocion Therapeutics is a biopharmaceutical company developing novel small molecule charged sodium channel blockers, "nocions", that selectively affect actively firing …See details»
Nocion Therapeutics Advances to Clinical Stage and Expands …
Nocion Therapeutics is a biopharmaceutical company developing novel small molecule charged sodium channel blockers, “nocions”, that selectively affect actively firing nociceptors to provide …See details»
Nocion Therapeutics - Craft
See insights on Nocion Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Catalent Supports Nocion Therapeutics’ Clinical Trial Materials
Sep 28, 2020 · Nocion Therapeutics is a biopharmaceutical company developing novel small molecule charged sodium channel blockers, “nocions”, that selectively affect actively firing …See details»
Nocion Therapeutics - VentureRadar
Website: http://www.nociontx.com/ Develops small molecule sodium channel blockers for potential treatment of conditions involving cough, itch, and pain, working with Harvard and Boston …See details»
Nocion Therapeutics Announces $62 Million Series B Financing to …
Mar 4, 2024 · Nocion is developing first and potentially best in class, small molecule, permanently charged sodium channel blockers (CSCBs), called nocions, that selectively silence activated …See details»
Nocion Therapeutics Appoints Dr. Catherine Bonuccelli to …
Jul 8, 2024 · Nocion Therapeutics is a biopharmaceutical company developing novel small molecule charged sodium channel blockers called “nocions” that selectively affect actively …See details»
Nocion Therapeutics - Overview, News & Similar companies
Aug 31, 2021 · View Nocion Therapeutics (www.nociontx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Anna Levengood - Nocion Therapeutics, Inc. | LinkedIn
Demonstrate your knowledge and understanding of clinical data management by becoming an SCDM Certified Clinical Data Manager (CCDM). There are many benefits to gaining …See details»
Attorney General Ken Paxton Sues Austin Taxpayer-Funded
3 days ago · “Drug activity and criminal behavior facilitated by this organization have hijacked an entire neighborhood,” said Attorney General Paxton. “By operating a taxpayer-funded drug …See details»
Nocion Therapeutics Doses First Patient in ASPIRE Phase 2b …
Nov 18, 2024 · Nocion Therapeutics is a biopharmaceutical company developing novel small molecule charged sodium channel blockers called “nocions” that selectively affect actively …See details»
Dr. Advisory Board and Joan Shaw to Senior Vice President, Clinical ...
Jul 8, 2024 · Nocion Therapeutics is a biopharmaceutical company developing novel small molecule charged sodium channel blockers called “nocions” that selectively affect actively …See details»